3 research outputs found
Hair cortisol-a method to detect chronic cortisol levels in patients with Prader-Willi syndrome
Background: Prader-Willi syndrome (PWS) is a multisymptomatic, rare, genetic, neurodevelopmental disorder in
adults mainly characterized by hyperphagia, cognitive dysfunction, behavioral problems and risk of morbid obesity.
Although endocrine insufficiencies are common, hypocortisolism is rare and knowledge on long-term cortisol
concentrations is lacking. The aim of this study was to evaluate long-term cortisol levels in PWS by measurements
of hair cortisol.
Methods: Twenty-nine adults with PWS, 15 men and 14 women, median age 29 years, median BMI 27 kg/m2
, were
included. Scalp hair samples were analyzed for cortisol content using liquid-chromatography tandem-mass
spectrometry. In addition, a questionnaire on auxology, medication and stress were included. For comparison, 105
age- and sex-matched participants from the population-based Lifelines Cohort study were included as controls. The
mean hair cortisol between the groups were compared and associations between BMI and stress were assessed by
a generalized linear regression model.
Results: In the PWS group large variations in hair cortisol was seen. Mean hair cortisol was 12.8 ± 25.4 pg/mg
compared to 3.8 ± 7.3 pg/mg in controls (p = 0.001). The linear regression model similarly showed higher cortisol
levels in patients with PWS, which remained consistent after adjusting for BMI and stress (p = 0.023). Furthermore,
hair cortisol increased with BMI (p = 0.012) and reported stress (p = 0.014).
Conclusion: Long-term cortisol concentrations were higher in patients with PWS compared to controls and
increased with BMI and stress, suggesting an adequate cortisol response to chronic stress. Hair cortisol demonstrate
promising applications in the context of PWS treatment and disease management
Central Adrenal Insufficiency Is Rare in Adults With Prader-Willi Syndrome
CONTEXT: Prader-Willi syndrome (PWS) is associated with several hypothalamic-pituitary hormone deficiencies. There is no agreement on the prevalence of central adrenal insufficiency (CAI) in adults with PWS. In some countries, it is general practice to prescribe stress-dose hydrocortisone during physical or psychological stress in patients with PWS. Side effects of frequent hydrocortisone use are weight gain, osteoporosis, diabetes mellitus, and hypertension-already major problems in adults with PWS. However, undertreatment of CAI can cause significant morbidity-or even mortality. OBJECTIVE: To prevent both over- and undertreatment with hydrocortisone, we assessed the prevalence of CAI in a large international cohort of adults with PWS. As the synacthen test shows variable results in PWS, we only use the metyrapone test (MTP) and insulin tolerance test (ITT). DESIGN: Metyrapone test or ITT in adults with PWS (N = 82) and review of medical files for symptoms of hypocortisolism related to surgery (N = 645). SETTING: Outpatient clinic. PATIENTS OR OTHER PARTICIPANTS: Eighty-two adults with genetically confirmed PWS. MAIN OUTCOME MEASURE: For MTP, 11-deoxycortisol > 230 nmol/L was considered sufficient. For ITT, cortisol > 500 nmol/L (Dutch, French, and Swedish patients) or > 450 nmol/L (British patients) was considered sufficient. RESULTS: Central adrenal insufficiency was excluded in 81 of 82 patients. Among the 645 patients whose medical files were reviewed, 200 had undergone surgery without perioperative hydrocortisone treatment. None of them had displayed any features of hypocortisolism. CONCLUSIONS: Central adrenal insufficiency is rare (1.2%) in adults with PWS. Based on these results, we recommend against routinely prescribing hydrocortisone stress-doses in adults with PWS